Clinical trials sponsored by Pfizer
48
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 11Phase 2 15Phase 3 16Phase 4 2Not applicable 10
Conditions studied
Recruiting trials led by Pfizer
- A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
- A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
- A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
- A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
- A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
- A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
- A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
- Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
- Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Korean Post-marketing Surveillance for Xeljanz XR
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- Phase 1 Study of PF-08046033 in Advanced Solid Tumors
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
- Study of PF-07248144 in Advanced or Metastatic Solid Tumors
- Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
- Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Common questions
How many trials is Pfizer recruiting for?
Pfizer is the lead sponsor of 48 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.